The clinical study of staphylococcal protein A immunoadsorption in the treatment of generalized myasthenia gravis

ZHAO Chongbo,LIU Junfeng,ZHU Wenhua,LIN Jie,XUE Jun,LI Xiang,LU Jiahong
DOI: https://doi.org/10.3969/j.issn.1002-0152.2007.09.007
2007-01-01
Abstract:Objective To study the efficacy and safety of staphylococcal protein A immunoadsorption in the treatment of generalized myasthenia gravis.Methods Nineteen cases of definitely diagnosed generalized MG were treated with protein A immunoadsorption.Clinical and safety assessments were evaluated at baseline and after the first and second immunoadsorption.Results At the end of treatment,Osserman grade,MGFA,ADL and MMT were improved significantly(P<0.0001).Accordingly,serum IgG,IgA and IgM concentrations were decreased significantly(P<0.0001).Individuals with positive AChR antibody were found to have a lower titer after treatment.The percentage of peripheral regulatory T cells was increased after treatment.Some patients had mild side effect,but the general tolerance was good.All the safety parameters showed no significant difference between baseline and post-treatment.Conclusions With possible mild side effect,staphylococcal protein A immunoadsorption could improve the symptoms of generalized myasthenia gravis quickly.
What problem does this paper attempt to address?